Obesity Clinical Trial
— I-POPOfficial title:
The Role of Community Health Workers to Reduce Health Disparities Using a Multi-Level Integrated Population Health Intervention
Verified date | February 2023 |
Source | Baylor Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary aim of this study is to determine whether community health worker (CHW) navigation improves outcomes of chronic disease and chronic disease risk factors in a low-income, primarily ethnic minority population when combined with an evidence-based population health model as compared to usual care after 10 months.
Status | Active, not recruiting |
Enrollment | 202 |
Est. completion date | July 31, 2023 |
Est. primary completion date | May 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: - Age 18 years or older - Ability to alter diet and/or physical activity - Willing to participate in a 10-month study - Resident of selected zip codes: 75210, 75215, 75216, 75217, 75223, or 75227 - Not having utilized BSW HWC membership services within the past 12 months - Not planning to move outside of the selected zip code area within the next 6 months Exclusion Criteria: - Below the age of 18 years - Unable or unwilling to alter diet and/or physical activity - Not willing to participate in a 10-month study - Not resident of local selected zip codes: 75210, 75215, 75216, 75217, 75223, or 75227 - Currently using or have used BSW HWC membership services within the past 12 months - Planning to move outside of the selected zip code area within the next 6 months |
Country | Name | City | State |
---|---|---|---|
United States | Baylor Research Institute | Dallas | Texas |
Lead Sponsor | Collaborator |
---|---|
Baylor Research Institute |
United States,
Chang A, Patberg E, Cueto V, Li H, Singh B, Kenya S, Alonzo Y, Carrasquillo O. Community Health Workers, Access to Care, and Service Utilization Among Florida Latinos: A Randomized Controlled Trial. Am J Public Health. 2018 Sep;108(9):1249-1251. doi: 10.2105/AJPH.2018.304542. Epub 2018 Jul 19. — View Citation
Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA. 2016 Jun 7;315(21):2284-91. doi: 10.1001/jama.2016.6458. — View Citation
Howard JT, Sparks PJ. Does allostatic load calculation method matter? Evaluation of different methods and individual biomarkers functioning by race/ethnicity and educational level. Am J Hum Biol. 2016 Sep 10;28(5):627-35. doi: 10.1002/ajhb.22843. Epub 2016 Feb 15. — View Citation
Johnson TL, Van Der Heijde M, Davenport S, et al. Population health in primary care: Cost, quality and experience impact. The American Journal of Accountable Care. 2017;5(3):10-20.
Kim K, Choi JS, Choi E, Nieman CL, Joo JH, Lin FR, Gitlin LN, Han HR. Effects of Community-Based Health Worker Interventions to Improve Chronic Disease Management and Care Among Vulnerable Populations: A Systematic Review. Am J Public Health. 2016 Apr;106(4):e3-e28. doi: 10.2105/AJPH.2015.302987. Epub 2016 Feb 18. — View Citation
Kindig D, Stoddart G. What is population health? Am J Public Health. 2003 Mar;93(3):380-3. doi: 10.2105/ajph.93.3.380. — View Citation
Kitzman H, Dodgen L, Mamun A, Slater JL, King G, Slater D, King A, Mandapati S, DeHaven M. Community-based participatory research to design a faith-enhanced diabetes prevention program: The Better Me Within randomized trial. Contemp Clin Trials. 2017 Nov;62:77-90. doi: 10.1016/j.cct.2017.08.003. Epub 2017 Aug 12. — View Citation
Lushniak BD, Alley DE, Ulin B, Graffunder C. The National Prevention Strategy: leveraging multiple sectors to improve population health. Am J Public Health. 2015 Feb;105(2):229-31. doi: 10.2105/AJPH.2014.302257. No abstract available. — View Citation
Nelson HD, Cantor A, Wagner J, Jungbauer R, Quinones A, Fu R, Stillman L, Kondo K. Achieving Health Equity in Preventive Services [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Dec. Report No.: 20-EHC002-EF. Available from http://www.ncbi.nlm.nih.gov/books/NBK550958/ — View Citation
Paskett E, Thompson B, Ammerman AS, Ortega AN, Marsteller J, Richardson D. Multilevel Interventions To Address Health Disparities Show Promise In Improving Population Health. Health Aff (Millwood). 2016 Aug 1;35(8):1429-34. doi: 10.1377/hlthaff.2015.1360. — View Citation
Tan M, Mamun A, Kitzman H, Dodgen L. Longitudinal Changes in Allostatic Load during a Randomized Church-based, Lifestyle Intervention in African American Women. Ethn Dis. 2019 Apr 18;29(2):297-308. doi: 10.18865/ed.29.2.297. eCollection 2019 Spring. — View Citation
Tan M, Mamun A, Kitzman H, Mandapati SR, Dodgen L. Neighborhood Disadvantage and Allostatic Load in African American Women at Risk for Obesity-Related Diseases. Prev Chronic Dis. 2017 Nov 22;14:E119. doi: 10.5888/pcd14.170143. — View Citation
Upchurch DM, Stein J, Greendale GA, Chyu L, Tseng CH, Huang MH, Lewis TT, Kravitz HM, Seeman T. A Longitudinal Investigation of Race, Socioeconomic Status, and Psychosocial Mediators of Allostatic Load in Midlife Women: Findings From the Study of Women's Health Across the Nation. Psychosom Med. 2015 May;77(4):402-12. doi: 10.1097/PSY.0000000000000175. — View Citation
Wesson D, Kitzman H, Halloran KH, Tecson K. Innovative Population Health Model Associated With Reduced Emergency Department Use And Inpatient Hospitalizations. Health Aff (Millwood). 2018 Apr;37(4):543-550. doi: 10.1377/hlthaff.2017.1099. — View Citation
Wesson DE, Kitzman HE. How Academic Health Systems Can Achieve Population Health in Vulnerable Populations Through Value-Based Care: The Critical Importance of Establishing Trusted Agency. Acad Med. 2018 Jun;93(6):839-842. doi: 10.1097/ACM.0000000000002140. — View Citation
* Note: There are 15 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Allostatic load | A composite score of 10 biomarkers to measure chronic stress and health outcomes. The biomarkers are BMI, waist-to-hip ratio, HDL, TC/HDL ratio, triglycerides, HbA1c, SBP, DBP, C-reactive protein, and cortisol. For each marker a value of 1 will be assigned if that exceed the third quartile except for HDL where a value of 1 will be assigned if lower than first quartile; otherwise a score of zero will be assigned. [scale: Count of risk factors. May be dichotomized as high risk = 6 to 10, low risk=0 to 5] | Baseline | |
Primary | Allostatic load | A composite score of 10 biomarkers to measure chronic stress and health outcomes. The biomarkers are BMI, waist-to-hip ratio, HDL, TC/HDL ratio, triglycerides, HbA1c, SBP, DBP, C-reactive protein, and cortisol. For each marker a value of 1 will be assigned if that exceed the third quartile except for HDL where a value of 1 will be assigned if lower than first quartile; otherwise a score of zero will be assigned. [scale: Count of risk factors. May be dichotomized as high risk = 6 to 10, low risk=0 to 5]. | 6-months | |
Primary | Cortisol | 4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 0.007 - 0.115 ug/dL. Value exceeded the normal range indicates higher level of stress.] | Baseline | |
Primary | Cortisol | 4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 0.007 - 0.115 ug/dL. Value exceeded the normal range indicates higher level of stress.] | 6-months | |
Primary | C-Reactive protein | 4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 25 pg/mL - 1600 pg/mL. Value exceeded the normal range indicates higher level of inflammation.] | Baseline | |
Primary | C-Reactive protein | 4mL saliva collected fasting in the morning. [Scale: measured in a continuous scale. Normal range 25 pg/mL - 1600 pg/mL. Value exceeded the normal range indicates higher level of inflammation.] | 6-months | |
Primary | Body mass index | Weight in pounds (lbs) divided by height in inches (in) squared and multiplying by a conversion factor of 703 | Baseline | |
Primary | Body mass index | Weight in pounds (lbs) divided by height in inches (in) squared and multiplying by a conversion factor of 703 | 6-months | |
Primary | Body mass index | Weight in pounds (lbs) divided by height in inches (in) squared and multiplying by a conversion factor of 703 | 10-months | |
Primary | Waist - to - Hip ratio | Waist circumference (centimeters) divided by circumference of hips (centimeters) | Baseline | |
Primary | Waist - to - Hip ratio | Waist circumference (centimeters) divided by circumference of hips (centimeters) | 6-months | |
Primary | Waist - to - Hip ratio | Waist circumference (centimeters) divided by circumference of hips (centimeters) | 10-months | |
Primary | HbA1c | Finger stick blood measure (%) | Baseline | |
Primary | HbA1c | Finger stick blood measure (%) | 6-months | |
Primary | HbA1c | Finger stick blood measure (%) | 10-months | |
Primary | Lipids | Finger stick blood measure collected fasting via fingerstick (mg/dL) | Baseline | |
Primary | Lipids | Finger stick blood measure collected fasting via fingerstick (mg/dL) | 6-months | |
Primary | Lipids | Finger stick blood measure collected fasting via fingerstick (mg/dL) | 10-months | |
Primary | Blood pressure | Stadiometer used to measure systolic and diastolic pressures to nearest 1 mm Hg | Baseline | |
Primary | Blood pressure | Stadiometer used to measure systolic and diastolic pressures to nearest 1 mm Hg | 6-months | |
Primary | Blood pressure | Stadiometer used to measure systolic and diastolic pressures to nearest 1 mm Hg | 10-months | |
Secondary | Diet | Measured by self report Dietary Screening questionnaire (DSQ). [scale: dietary nutrients will be calculated on a continuous scale based on NHANES guideline. Score: 0 to any positive value. A score above or below the threshold based on 2000 calories per day would indicate worse outcome.] | Baseline | |
Secondary | Diet | Measured by self report Dietary Screening questionnaire (DSQ). [scale: dietary nutrients will be calculated on a continuous scale based on NHANES guideline. Score: 0 to any positive value. A score above or below the threshold based on 2000 calories per day would indicate worse outcome.] | 6-months | |
Secondary | Diet | Measured by self report Dietary Screening questionnaire (DSQ). [scale: dietary nutrients will be calculated on a continuous scale based on NHANES guideline. Score: 0 to any positive value. A score above or below the threshold based on 2000 calories per day would indicate worse outcome.] | 10-months | |
Secondary | Physical activity | Measured by self report questionnaire [type, frequency, and time completed in minutes] | Baseline | |
Secondary | Physical activity | Measured by self report questionnaire [type, frequency, and time completed in minutes] | 6-months | |
Secondary | Physical activity | Measured by self report questionnaire [type, frequency, and time completed in minutes] | 10-months | |
Secondary | Services utilization | Measured by self-report survey. [scale: count the number visits at healthcare or wellness centers. A higher score would indicate better utilization.] | Baseline | |
Secondary | Services utilization | Measured by self-report survey. [scale: count the number visits at healthcare or wellness centers. A higher score would indicate better utilization.] | 6-months | |
Secondary | Services utilization | Measured by self-report survey. [scale: count the number visits at healthcare or wellness centers. A higher score would indicate better utilization.] | 10-months | |
Secondary | Social determinants | Measured by self-report survey | Baseline | |
Secondary | Social determinants | Measured by self-report survey | 6-months | |
Secondary | Social determinants | Measured by self-report survey | 10-months | |
Secondary | Perceived stress | Measured by Perceived Stress Scale (PSS-10) [scale: high risk=40, moderate risk=20, low risk=0] | Baseline | |
Secondary | Perceived stress | Measured by Perceived Stress Scale (PSS-10) [scale: high risk=40, moderate risk=20, low risk=0] | 6-months | |
Secondary | Perceived stress | Measured by Perceived Stress Scale (PSS-10) [scale: high risk=40, moderate risk=20, low risk=0] | 10-months | |
Secondary | Medication use | Measured by self-report survey | Baseline | |
Secondary | Medication use | Measured by self-report survey | 6-months | |
Secondary | Medication use | Measured by self-report survey | 10-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |